Trilogy Capital’s AB Ultra Short Income ETF YEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$922K Sell
18,307
-82
-0.4% -$4.13K 0.04% 209
2026
Q1
$928K Sell
18,389
-545
-3% -$27.5K 0.04% 200
2025
Q4
$956K Sell
18,934
-2,264
-11% -$115K 0.04% 192
2025
Q3
$1.07M Buy
21,198
+22
+0.1% +$1.11K 0.05% 175
2025
Q2
$1.07M Sell
21,176
-8,090
-28% -$409K 0.05% 174
2025
Q1
$1.48M Sell
29,266
-4,408
-13% -$223K 0.08% 152
2024
Q4
$1.7M Buy
33,674
+3,398
+11% +$172K 0.09% 154
2024
Q3
$1.54M Buy
30,276
+1,851
+7% +$93.7K 0.08% 156
2024
Q2
$1.44M Sell
28,425
-2,117
-7% -$107K 0.08% 149
2024
Q1
$1.54M Sell
30,542
-5,864
-16% -$296K 0.09% 144
2023
Q4
$1.83M Sell
36,406
-28,975
-44% -$1.45M 0.11% 130
2023
Q3
$3.28M Sell
65,381
-1,530
-2% -$76.7K 0.22% 63
2023
Q2
$3.36M Buy
66,911
+35,615
+114% +$1.79M 0.21% 73
2023
Q1
$1.57M Buy
+31,296
New +$1.57M 0.11% 113

Other funds holding YEAR

Trilogy Capital's YEAR Position: Q2 2026 in Review

Trilogy Capital reduced its AB Ultra Short Income ETF (YEAR) stake by 0.45% in Q2 2026, selling an estimated $4.13K and leaving 18,307 shares worth $922K. The position accounts for 0.04% of the portfolio, ranked #209.

Trilogy Capital first reported a position in YEAR in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.36M in Q2 2023. 11 funds tracked by Wall St. Rank hold YEAR as of Q2 2026.

  • Trilogy Capital held 18,307 shares of AB Ultra Short Income ETF worth $922K as of Q2 2026.
  • Trilogy Capital sold 82 AB Ultra Short Income ETF shares in Q2 2026, an estimated $4.13K.
  • AB Ultra Short Income ETF made up 0.04% of Trilogy Capital's portfolio in Q2 2026, its #209 holding.
  • Trilogy Capital first reported a position in AB Ultra Short Income ETF in Q1 2023 and has held it in 14 quarters since.
  • Trilogy Capital's AB Ultra Short Income ETF position peaked at $3.36M in Q2 2023.
  • 11 funds tracked by Wall St. Rank held AB Ultra Short Income ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.